Clinical medications which inhibit or imitate normal functionality of the sympathetic and parasympathetic nervous systems are referred to as autonomic drugs. These are primarily utilized for the management of gastrointestinal, urinary tract, cardiovascular, and respiratory disorders (Cancado, Mendes, Arana, Horvath, Monzon, Salathe, & Wanner, 2015). The autonomic system is a vital component of the central nervous system and is responsible for the control of visceral or voluntary body functions. It influences the respiratory, urinary, digestive, respiratory, and reproductive systems as well as playing a critical role in the body’s reactions to stress (Sohn, Harris, Berglund, Liu, Vong, Lowell & Elmquist, 2013). The sympathetic nervous system and parasympathetic are subordinate to the autonomous nervous system. The sympathetic system is concerned with flight or flight and the body’s effectiveness under stress. The parasympathetic nervous system purposes to control vegetative functionality like feeding, resting, breeding and repose and is notably in unceasing contradiction to the sympathetic system. It is therefore crucial to gain an appropriate understanding of how autonomous drugs like Albuterol, Belladonna and Ipratropium Bromide impact on the sympathetic and parasympathetic nervous systems.
This drug is categorized as bronchodilator and functions by opening up airway